GB Sciences (OTCMKTS:GBLX) Stock Crosses Above Fifty Day Moving Average – Should You Sell?

GB Sciences, Inc. (OTCMKTS:GBLX – Get Free Report) crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.00 and traded as high as $0.0003. GB Sciences shares last traded at $0.0003, with a volume of 76,611 shares changing hands.

GB Sciences Price Performance

GB Sciences Company Profile

(Get Free Report)

GB Sciences, Inc is a biotechnology company focused on the research, development and commercialization of cannabinoid-based medicines. Leveraging both botanical and synthetic approaches, the company aims to create novel therapies targeting oncology, neurology and inflammatory diseases. Through its proprietary drug discovery platform, GB Sciences seeks to identify and advance lead compounds that harness the therapeutic potential of cannabinoids while ensuring high standards of quality and safety.

The company operates a cGMP-compliant research and manufacturing facility in Irvine, California, and maintains partnerships to support cultivation and extraction activities in select geographies.

See Also

• Five stocks we like better than GB Sciences
• 3 ETFs Giving Ready-Made Access to the Discounted International Small-Cap Space
• What to Expect From Q2 Earnings as Tech Strength Broadens
• Viasat’s Orbiting Profits: Space Force Jackpot?
• Robinhood Wants a Bigger Role in IPOs—Here’s Why It Matters